Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks
New Covid variant detected and vaccines are less effective and LDN could provide treatment options for new variant
I agreed. Amazingly he kept repeating that I said the stock price will go .16 which I never said. I given range anywhere from .05-.16 depending on cyto success.
600K bid size
CBLI & CYTO combined will have 4-5 phase 3 trials target opportunities are over 50-100B and Big pharma will love to acquire the company after the merger.
Pure manipulation tremendously undervalued
Amazingly $IBRX $6.5B MCAP, just when through reverse merger with $NK similar to the $CYTO & CBLI $74M MCAP
Probably low valuation of TOMDF & massive dilution occurred in past year that have reduced their equity stake and huge uncertainty about up listing into nasdaq. I’m big fan of the company but very disappointed with current stock price.
Phase 2 trial Impact of Colchicine and Low-dose Naltrexone on COVID-19 (COLTREXONE)
https://www.clinicaltrials.gov/ct2/show/NCT04756128
Provista deal is not closed
I saw that and IMUN will own ?
3,296,584.70, which will be the largest shareholder.
I never said it would be .16 but “could be” depends on CBLI success
Lol
I think so
IMUN 13.5% equity stake on cyto is huge. Let me put into prospective. According to S4 filed the valuation of the merger was 326M *.13.5% = $44M IMUN equity stake on cyto
I think so! 13.5% equity stakes CYTO is huge
Griffin, 49,772 shares associated with a convertible note held Global Reverb Corp
Thanks
Where do you see that
Agreed! Pure manipulation and nothing else. It’s ridiculous to say that the assets are worth 30,000. Secondly to think that CBLI will not $15 SP is completely foolish.
Lol “growing revenues and expanding business model” what foolish statement. Dilution will keep the stock price down and keep praising GC for fabulous job. No body hate GC we judged him based on his job record which are terrible. Keep posting garbage
Lol you are clueless pathetic loser. Who keeps posting nonsense.
I received an email from IMUN CEO “We hope to make some announcements soon regarding the future of the Company. We will be filing out own 10K Auunal Report tomorrow. It will be available on our website.”
Agreed. I would like Grant Magers to be the new CEO.
Lol you are unbelievable! Any time the SP dips you always have to say something. I made clear you body really care what you have to say. Lol go find a hobby to spend your time and don’t waste time posting on this board
What foolish comment and you praised a professional con artist.
Lol pretty stupid claim. I retweet’s a lot yesterday
I tried to access the report but payment is required
Everyone is silent today!
Amazing $IBRX increased 3B to 12.5B after reverse merger with NK
How is that related to TOMDF
Thanks.
Thanks!
What interview
The ceo quote “The early data the potential of CYTO-205, as both an interventional therapy & preventative agent for #covid19 is compelling”
Based on that maybe IMUN owns 85%
The company haven’t disclosed the equity stake “it will retain a major equity stake in Forte” I’m assuming more than 10%
Absolutely! The company hired new controller KATHLEEN BROWNE & new company website looks great.
FORTE BIOTECHNOLOGY
Forte Biotechnology is an animal health focused biotech company preparing to exit stealth in the coming months. As part of IMUN’s continuing strategy, it will retain a major equity stake in Forte
OyaGen very promising technology
ROC company reports breakthroughs in drug to treat COVID; focus remains on vaccine
https://13wham.com/news/local/roc-company-reports-breakthroughs-in-a-drug-to-treat-covid-yet-focus-remains-on-vaccine